| Year |
Citation |
Score |
| 2024 |
Xie X, Yang M, Wei X, Chu H, Zhao W, Shen N. Dual immunostimulatory CD73 antibody-polymeric cytotoxic drug complex for triple negative breast cancer therapy. Acta Biomaterialia. PMID 39341438 DOI: 10.1016/j.actbio.2024.09.033 |
0.312 |
|
| 2024 |
Zhai P, Zhang H, Li Q, Hu Z, Zhang H, Yang M, Xing C, Guo Y. SETBP1 activation upon MDM4-enhanced ubiquitination of NR3C1 triggers dissemination of colorectal cancer cells. Clinical & Experimental Metastasis. PMID 38796806 DOI: 10.1007/s10585-024-10294-2 |
0.346 |
|
| 2022 |
Yang M, Brackenbury WJ. Harnessing the Membrane Potential to Combat Cancer Progression. Bioelectricity. 4: 75-80. PMID 39350772 DOI: 10.1089/bioe.2022.0001 |
0.669 |
|
| 2022 |
Shen Y, Ye H, Zhang D, Yang M, Ji Y, Tang L, Zhu X, Yuan L. The role of exosomal CDC6 in the hirudin-mediated suppression of the malignant phenotype of bladder cancer cells. Gene. 146269. PMID 35150820 DOI: 10.1016/j.gene.2022.146269 |
0.308 |
|
| 2022 |
Niu X, Yin L, Yang X, Yang Y, Gu Y, Sun Y, Yang M, Wang Y, Zhang Q, Ji H. Serum amyloid A 1 induces suppressive neutrophils through the Toll-like receptor 2-mediated signaling pathway to promote progression of breast cancer. Cancer Science. PMID 35102665 DOI: 10.1111/cas.15287 |
0.355 |
|
| 2020 |
Simon A, Yang M, Marrison JL, James AD, Hunt MJ, O'Toole PJ, Kaye PM, Whittington MA, Chawla S, Brackenbury WJ. Metastatic breast cancer cells induce altered microglial morphology and electrical excitability in vivo. Journal of Neuroinflammation. 17: 87. PMID 32192526 DOI: 10.1186/S12974-020-01753-0 |
0.636 |
|
| 2019 |
Yang M, James AD, Suman R, Kasprowicz R, Nelson M, O'Toole PJ, Brackenbury WJ. Voltage-dependent activation of Rac1 by Na 1.5 channels promotes cell migration. Journal of Cellular Physiology. PMID 31612502 DOI: 10.1002/Jcp.29290 |
0.664 |
|
| 2016 |
Mohammed FH, Khajah MA, Yang M, Brackenbury WJ, Luqmani YA. Blockade of voltage-gated sodium channels inhibits invasion of endocrine-resistant breast cancer cells. International Journal of Oncology. 48: 73-83. PMID 26718772 DOI: 10.3892/Ijo.2015.3239 |
0.699 |
|
| 2015 |
Nelson M, Yang M, Millican-Slater R, Brackenbury WJ. Nav1.5 regulates breast tumor growth and metastatic dissemination in vivo. Oncotarget. PMID 26452220 DOI: 10.18632/Oncotarget.5441 |
0.703 |
|
| 2015 |
Nelson M, Yang M, Dowle AA, Thomas JR, Brackenbury WJ. The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis. Molecular Cancer. 14: 13. PMID 25623198 DOI: 10.1186/S12943-014-0277-X |
0.698 |
|
| 2015 |
Brackenbury WJ, Nelson M, Yang M, Dowle AA, Thomas JR. Abstract P6-03-10: Targeting voltage-gated sodium channels with the antiepileptic drug phenytoin inhibits breast tumor growth and metastasis Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-03-10 |
0.658 |
|
| 2013 |
Yang M, Brackenbury WJ. Membrane potential and cancer progression. Frontiers in Physiology. 4: 185. PMID 23882223 DOI: 10.3389/Fphys.2013.00185 |
0.679 |
|
| 2012 |
Yang M, Kozminski DJ, Wold LA, Modak R, Calhoun JD, Isom LL, Brackenbury WJ. Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer. Breast Cancer Research and Treatment. 134: 603-15. PMID 22678159 DOI: 10.1007/S10549-012-2102-9 |
0.704 |
|
| Show low-probability matches. |